Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
about
Intrathecal baclofen for treating spasticity in children with cerebral palsyIntrathecal baclofen for treating spasticity in children with cerebral palsyThe management of scoliosis in children with cerebral palsy: a reviewThe need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database.Unusual placement of intrathecal baclofen pumps: report of two cases.Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administrationA history of intraspinal analgesia, a small and personal journey.Societal costs of intrathecal drug delivery systems--an administrative analysis based on patient claims.Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications.Intrathecal baclofen therapy in children with acquired brain injuries after drowning: A case series.A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.Medical cost impact of intrathecal baclofen therapy for severe spasticity.Cost-effectiveness analysis of a system-based approach for managing neonatal jaundice and preventing kernicterus in Ontario.Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland.Neuromodulation for spasticity and dystonia.Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis.Economic evaluation and cost of interventions for cerebral palsy: a systematic review.Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity.
P2860
Q24187762-23954D6E-8A2B-4418-8D10-C4486214F062Q24247608-0C9F8EAE-E795-4E0A-81D0-E66AFA958C26Q34549520-FB80F588-049A-4843-8B09-402CA55A534AQ35803252-969FE81E-66B7-4F12-B302-A85B4D415A71Q36385535-6B32DD87-5FFA-49C2-973A-2AC972937888Q36642679-B74C3383-A608-4411-B05F-1CDB71204AE0Q37996441-2CEEA443-6C04-48BA-A2FD-0EBE8739494AQ38082835-5698BA34-06B5-457E-A91C-CCD61ED8E9E5Q38131529-7A61E69E-F3C8-41E5-A126-D1E1CFCB88AEQ38255212-0DB3C0E6-D85D-4041-A3A2-A1E163E25490Q38370304-858E0640-56E3-4CAC-A3B8-B833DFC0869DQ39141856-BDFB7823-D44F-46C1-AD5B-0E93576F92DDQ40991088-D12F0F38-9965-4C3F-B59D-501DB4229B37Q41938150-B3A37556-6187-4BDD-8985-DA4A0CC883B7Q43473646-60909B52-2F77-4265-9E8C-E54A6ED3D53CQ46116604-5AB27FA7-5784-483D-A57A-1028AABB2951Q47556034-6EB3072E-5179-4AAB-88EE-EF85130308A4Q47566061-B7436D81-4D51-4CE4-9196-333D7CD73CF0Q47662647-ED16E408-6CE7-4F15-A2A2-CC129056E83A
P2860
Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cost-effectiveness of intrathe ...... ssociated with cerebral palsy.
@en
type
label
Cost-effectiveness of intrathe ...... ssociated with cerebral palsy.
@en
prefLabel
Cost-effectiveness of intrathe ...... ssociated with cerebral palsy.
@en
P2093
P2860
P356
P1476
Cost-effectiveness of intrathe ...... ssociated with cerebral palsy.
@en
P2093
Gregory de Lissovoy
Hannah Green
Louis S Matza
Meghan Werner
Terence Edgar
P2860
P356
10.1177/0883073807299976
P577
2007-01-01T00:00:00Z